Skip to content
PeptideAgent

Compounding pharmacies in Pennsylvania

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The Pennsylvania State Board of Pharmacy (Department of State, Bureau of Professional and Occupational Affairs) regulates compounding pharmacies in Pennsylvania. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Pennsylvania at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Pennsylvania

No verified compounding pharmacies serving Pennsylvania are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Pennsylvania

The State Board of Pharmacy licenses pharmacies under the Pharmacy Act (63 P.S. section 390-1 and following) and regulates practice through 49 Pa. Code chapter 27. The compounding rules at 49 Pa. Code sections 27.601 to 27.606 (effective June 22, 2019) require sterile and non-sterile compounding to follow section 503A of the federal Food, Drug, and Cosmetic Act, its regulations, and the current USP compounding chapters; section 27.602 bars pharmacists from compounding drugs FDA has withdrawn for safety or effectiveness, essentially copies of commercially available drugs except as 503A allows, and drugs FDA has identified as not compoundable. Pennsylvania has not adopted a separate list of compoundable bulk substances, so a peptide's eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). Section 4.1 of the Pharmacy Act (63 P.S. section 390-4.1, added in 2015) requires a nonresident pharmacy to register with the Board every two years, hold a valid home-state license, submit its most recent home-state or national inspection report, and provide a toll-free pharmacist line, and it bars shipping legend drugs into Pennsylvania without that certificate of registration. The Board's license verification confirms registration. [1] [2] [3] [5]

Compounded GLP-1 access in Pennsylvania

Telehealth GLP-1 patients should confirm the dispensing pharmacy holds a Pennsylvania pharmacy permit or nonresident pharmacy registration. [1] [8]

Research use only sellers in Pennsylvania

The Pennsylvania Pharmacy Act restricts dispensing of prescription drugs to licensed pharmacies, and the Controlled Substance, Drug, Device and Cosmetic Act (35 P.S. section 780-101 and following) prohibits the sale of adulterated, misbranded, or unapproved new drugs in the Commonwealth. [2] [4] [9]

How to check a compounding pharmacy in Pennsylvania

  1. Search the Pennsylvania State Board of Pharmacy (Department of State, Bureau of Professional and Occupational Affairs) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Pennsylvania requires before it ships to you. [1] [2] [3] [5]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Pennsylvania. [2] [4] [9]

Common questions in Pennsylvania

Can an out-of-state pharmacy ship compounded peptides to me in Pennsylvania?

Only if it holds a certificate of registration from the Pennsylvania State Board of Pharmacy as a nonresident pharmacy. Section 4.1 of the Pharmacy Act (63 P.S. section 390-4.1) bars a nonresident pharmacy from shipping legend drugs into Pennsylvania without one. Search the Department of State license verification for the pharmacy name; if it is not registered, the shipment is not lawful in Pennsylvania even if the prescriber is compliant. [1] [2]

Can a Pennsylvania pharmacy compound BPC-157 or other unapproved peptides?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [3] [6] [7]

All peptide legal questions for Pennsylvania

Sources

  1. [1]Pennsylvania State Board of Pharmacy
  2. [2]Pennsylvania Pharmacy Act, Act of Sept. 27, 1961, P.L. 1700, No. 699 (63 P.S. section 390-1 and following), including section 4.1, Nonresident pharmacies
  3. [3]49 Pa. Code chapter 27, State Board of Pharmacy regulations (compounding, sections 27.601 to 27.606)
  4. [4]Pennsylvania Controlled Substance, Drug, Device and Cosmetic Act, 35 P.S. section 780-101 and following (Act 1972-64)
  5. [5]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  6. [6]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  7. [7]FDA: Pharmacy Compounding Advisory CommitteeFDA
  8. [8]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  9. [9]21 U.S.C. 331, Prohibited acts